Literature DB >> 22403426

A new and frequent human T-cell leukemia virus indeterminate Western blot pattern: epidemiological determinants and PCR results in central African inhabitants.

Claudia Filippone1, Sylviane Bassot, Edouard Betsem, Patricia Tortevoye, Micheline Guillotte, Odile Mercereau-Puijalon, Sabine Plancoulaine, Sara Calattini, Antoine Gessain.   

Abstract

Human T-cell leukemia virus (HTLV) indeterminate Western blot (WB) serological patterns are frequently observed in plasma/serum from persons living in intertropical areas. In the framework of ongoing projects on HTLV-1/2 and related viruses in Central Africa, we systematically analyzed plasma from villagers living in South Cameroon by WB. The group included 1,968 individuals (mean age, 44 years; age range, 5 to 90 years; 978 women/990 men), both Bantus (1,165) and Pygmies (803). Plasma samples were tested by WB analysis (MPD HTLV Blot 2.4) and interpreted according to the manufacturer's instructions. Only clear bands were considered in the analysis. Among the 1,968 plasma samples, 38 (1.93%) were HTLV-1, 13 (0.66%) were HTLV-2, and 6 (0.3%) were HTLV WB seropositive. Furthermore, 1,292 (65.65%) samples were WB sero-indeterminate, including 104 (5.28%) with an HTLV-1 Gag-indeterminate pattern (HGIP) and 68 (3.45%) with a peculiar yet unreported pattern exhibiting mostly a strong shifted GD21 and a p28. The other 619 (31.45%) samples were either WB negative or exhibited other patterns, mostly with unique p19 or p24 bands. DNA, extracted from peripheral blood buffy coat, was subjected to PCR using several primer pairs known to detect HTLV-1/2/3/4. Most DNAs from HTLV-1- and HTLV-seropositive individuals were PCR positive. In contrast, all the others, from persons with HTLV-2, HGIP, new WB, and other indeterminate patterns, were PCR negative. Epidemiological determinant analysis of the persons with this new peculiar WB pattern revealed that seroprevalence was independent from age, sex, or ethnicity, thus resembling the indeterminate profile HGIP rather than HTLV-1. Moreover, this new pattern persists over time.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22403426      PMCID: PMC3347141          DOI: 10.1128/JCM.06540-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  72 in total

1.  Significance of human T-lymphotropic virus type I indeterminant serological findings among healthy individuals.

Authors:  J J Lipka; K K Young; S Y Kwok; G R Reyes; J J Sninsky; S K Foung
Journal:  Vox Sang       Date:  1991       Impact factor: 2.144

2.  Detection and differentiation of antibodies to human T-cell lymphotropic virus types I and II by the immunofluorescence method.

Authors:  D Gallo; L M Penning; C V Hanson
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

3.  Distinguishing between HTLV-I and HTLV-II by western blot.

Authors:  S Z Wiktor; S S Alexander; G M Shaw; S H Weiss; E L Murphy; R J Wilks; V J Shortly; B Hanchard; W A Blattner
Journal:  Lancet       Date:  1990-06-23       Impact factor: 79.321

4.  Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study.

Authors:  Y Hinuma; H Komoda; T Chosa; T Kondo; M Kohakura; T Takenaka; M Kikuchi; M Ichimaru; K Yunoki; I Sato; R Matsuo; Y Takiuchi; H Uchino; M Hanaoka
Journal:  Int J Cancer       Date:  1982-06-15       Impact factor: 7.396

5.  Determination of a unique and immunodominant epitope of human T cell lymphotropic virus type I.

Authors:  J J Lipka; K Bui; G R Reyes; R Moeckli; S Z Wiktor; W A Blattner; E L Murphy; G M Shaw; C V Hanson; J J Sninsky
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

6.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

7.  A new agglutination test for serum antibodies to adult T-cell leukemia virus.

Authors:  M Ikeda; R Fujino; T Matsui; T Yoshida; H Komoda; J Imai
Journal:  Gan       Date:  1984-10

8.  Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and II.

Authors:  J J Lipka; P Santiago; L Chan; G R Reyes; K P Samuel; W A Blattner; G M Shaw; C V Hanson; J J Sninsky; S K Foung
Journal:  J Infect Dis       Date:  1991-08       Impact factor: 5.226

9.  Antibodies to human T lymphotropic virus type I in a population from the Philippines: evidence for cross-reactivity with Plasmodium falciparum.

Authors:  C G Hayes; J P Burans; R B Oberst
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

10.  Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients.

Authors:  A Manns; E L Murphy; R Wilks; G Haynes; J P Figueroa; B Hanchard; M Barnett; J Drummond; D Waters; M Cerney
Journal:  Blood       Date:  1991-02-15       Impact factor: 22.113

View more
  15 in total

1.  Proviral Features of Human T Cell Leukemia Virus Type 1 in Carriers with Indeterminate Western Blot Analysis Results.

Authors:  Madoka Kuramitsu; Tsuyoshi Sekizuka; Tadanori Yamochi; Sanaz Firouzi; Tomoo Sato; Kazumi Umeki; Daisuke Sasaki; Hiroo Hasegawa; Ryuji Kubota; Rieko Sobata; Chieko Matsumoto; Noriaki Kaneko; Haruka Momose; Kumiko Araki; Masumichi Saito; Kisato Nosaka; Atae Utsunomiya; Ki-Ryang Koh; Masao Ogata; Kaoru Uchimaru; Masako Iwanaga; Yasuko Sagara; Yoshihisa Yamano; Akihiko Okayama; Kiyonori Miura; Masahiro Satake; Shigeru Saito; Kazuo Itabashi; Kazunari Yamaguchi; Makoto Kuroda; Toshiki Watanabe; Kazu Okuma; Isao Hamaguchi
Journal:  J Clin Microbiol       Date:  2017-07-12       Impact factor: 5.948

Review 2.  Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

Authors:  Nicolas Legrand; Skye McGregor; Rowena Bull; Sahar Bajis; Braulio Mark Valencia; Amrita Ronnachit; Lloyd Einsiedel; Antoine Gessain; John Kaldor; Marianne Martinello
Journal:  Clin Microbiol Rev       Date:  2022-02-23       Impact factor: 50.129

Review 3.  HTLV-1: A real pathogen or a runaway guest of a diseased cell?

Authors:  L I B Kanzaki
Journal:  J Biosci       Date:  2018-09       Impact factor: 1.826

4.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

5.  Low Proviral Load is Associated with Indeterminate Western Blot Patterns in Human T-Cell Lymphotropic Virus Type 1 Infected Individuals: Could Punctual Mutations be Related?

Authors:  Camila Cánepa; Jimena Salido; Matías Ruggieri; Sindy Fraile; Gabriela Pataccini; Carolina Berini; Mirna Biglione
Journal:  Viruses       Date:  2015-10-28       Impact factor: 5.048

6.  Evaluation of Sensitivity and Specificity Performance of Elecsys HTLV-I/II Assay in a Multicenter Study in Europe and Japan.

Authors:  Syria Laperche; Silvia Sauleda; Maria Piron; Annelies Mühlbacher; Harald Schennach; Volkmar Schottstedt; Lucinda Queirós; Naoki Uno; Katsunori Yanagihara; Roland Imdahl; Ariann Hey; Markus Klinkicht; Walter Melchior; Peter Muench; Toshiki Watanabe
Journal:  J Clin Microbiol       Date:  2017-05-03       Impact factor: 5.948

7.  Performance of Commercially Available Serological Screening Tests for Human T-Cell Lymphotropic Virus Infection in Brazil.

Authors:  Vanessa da Silva Brito; Fred Luciano Neves Santos; Noilson Lazaro Sousa Gonçalves; Thessika Hialla Almeida Araujo; Davi Silva Vale Nascimento; Felicidade Mota Pereira; Ney Cristian Amaral Boa-Sorte; Maria Fernanda Rios Grassi; Adele Caterino-de-Araujo; Bernardo Galvão-Castro
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

8.  Epidemiology and genetic variability of HHV-8/KSHV in Pygmy and Bantu populations in Cameroon.

Authors:  Edouard Betsem; Olivier Cassar; Philippe V Afonso; Arnaud Fontanet; Alain Froment; Antoine Gessain
Journal:  PLoS Negl Trop Dis       Date:  2014-05-15

Review 9.  Seroprevalence of HTLV-1 and HTLV-2 amongst mothers and children in Malawi within the context of a systematic review and meta-analysis of HTLV seroprevalence in Africa.

Authors:  James M Fox; Nora Mutalima; Elizabeth Molyneux; Lucy M Carpenter; Graham P Taylor; Martin Bland; Robert Newton; Fabiola Martin
Journal:  Trop Med Int Health       Date:  2016-02-03       Impact factor: 2.622

10.  Revisiting human T-cell lymphotropic virus types 1 and 2 infections among rural population in Gabon, central Africa thirty years after the first analysis.

Authors:  Melanie Caron; Guillaume Besson; Cindy Padilla; Maria Makuwa; Dieudonne Nkoghe; Eric Leroy; Mirdad Kazanji
Journal:  PLoS Negl Trop Dis       Date:  2018-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.